Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Hafner, C; Houben, R; Baeurle, A; Ritter, C; Schrama, D; Landthaler, M; Becker, JC.
Activation of the PI3K/AKT pathway in Merkel cell carcinoma.
PLoS One. 2012; 7(2):e31255-e31255 Doi: 10.1371/journal.pone.0031255 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Co-authors Med Uni Graz
Becker Jürgen Christian
Ritter Cathrin
Schrama David
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Merkel cell carcinoma (MCC) is a highly aggressive skin cancer with an increasing incidence. The understanding of the molecular carcinogenesis of MCC is limited. Here, we scrutinized the PI3K/AKT pathway, one of the major pathways activated in human cancer, in MCC. Immunohistochemical analysis of 41 tumor tissues and 9 MCC cell lines revealed high levels of AKT phosphorylation at threonine 308 in 88% of samples. Notably, the AKT phosphorylation was not correlated with the presence or absence of the Merkel cell polyoma virus (MCV). Accordingly, knock-down of the large and small T antigen by shRNA in MCV positive MCC cells did not affect phosphorylation of AKT. We also analyzed 46 MCC samples for activating PIK3CA and AKT1 mutations. Oncogenic PIK3CA mutations were found in 2/46 (4%) MCCs whereas mutations in exon 4 of AKT1 were absent. MCC cell lines demonstrated a high sensitivity towards the PI3K inhibitor LY-294002. This finding together with our observation that the PI3K/AKT pathway is activated in the majority of human MCCs identifies PI3K/AKT as a potential new therapeutic target for MCC patients.
Find related publications in this database (using NLM MeSH Indexing)
Antigens, Polyomavirus Transforming - metabolism
Base Sequence -
Carcinoma, Basal Cell - enzymology Carcinoma, Basal Cell - pathology
Carcinoma, Merkel Cell - enzymology Carcinoma, Merkel Cell - genetics Carcinoma, Merkel Cell - pathology
Cell Line, Tumor -
Chromones - pharmacology
DNA Mutational Analysis -
Enzyme Activation - drug effects
Humans -
Molecular Sequence Data -
Morpholines - pharmacology
Mutation - genetics
Phosphatidylinositol 3-Kinases - antagonists and inhibitors Phosphatidylinositol 3-Kinases - genetics Phosphatidylinositol 3-Kinases - metabolism
Phosphorylation - drug effects
Phosphothreonine - metabolism
Proto-Oncogene Proteins c-akt - metabolism
Signal Transduction - drug effects
Skin Neoplasms - enzymology Skin Neoplasms - genetics Skin Neoplasms - pathology

© Med Uni GrazImprint